Patients cured of a malignant germ-cell tumor are at a significantly increased relative risk (RR, 1.3-2.1) of developing a new malignancy, the most frequent second cancer being a new germ-cell cancer. The exact role of modern treatment of germ-cell malignancies as an etiological factor of a subseque
β¦ LIBER β¦
Artificial heterogenization of malignant tumors. Second principle of immunological treatment of tumors
β Scribed by G. Ya. Svet-Moldavskii; V. P. Gamburg
- Publisher
- Springer US
- Year
- 1965
- Tongue
- English
- Weight
- 204 KB
- Volume
- 60
- Category
- Article
- ISSN
- 0007-4888
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Second cancer after treatment of maligna
β
S. D. FossΓ₯; E. Hoff WanderΓ₯s; K. Heimdal
π
Article
π
1994
π
Springer-Verlag
π
English
β 386 KB
Hypophysectomy in the treatment of malig
β
Rolf Luft; Herbert Olivecrona
π
Article
π
1957
π
John Wiley and Sons
π
English
β 500 KB
π 2 views
Surgical treatment of primary tracheobro
β
Hailong Wang; Zhenzong Du; Hua Ren; Chaoji Zhang; Jianfei Song; Yuepei Liang; An
π
Article
π
2010
π
Springer
π
English
β 196 KB
Results of treatment of malignant tumors
β
N. G. Blokhina; E. K. Vozny; A. M. Garin
π
Article
π
1972
π
John Wiley and Sons
π
English
β 220 KB
π 2 views
Treatment of malignant leydig cell tumor
β
Kenneth A. Bertram; Brian Bratloff; George F. Hodges; Howard Davidson
π
Article
π
1991
π
John Wiley and Sons
π
English
β 794 KB
Malignant Leydig cell tumors (LCT) are rare. Only 32 cases of malignant LCT (as evidenced by metastatic spread) were reported. Generally metastatic spread occurs within 2 years of the primary LCT, and the patient dies within 2 years of the discovery of metastatic disease. The tumor is highly resista
Treatment of malignant tumors in the par
β
Jens Witten; Finn Hybert; Hanne Sand Hansen
π
Article
π
1990
π
John Wiley and Sons
π
English
β 535 KB